首页/数据集/Dataset from A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Flexible-Dose Study of DVS-233 SR and Venlafaxine ER in Adult Outpatients With Major Depressive Disorder

Dataset from A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Flexible-Dose Study of DVS-233 SR and Venlafaxine ER in Adult Outpatients With Major Depressive Disorder

NIAID Data Ecosystem2026-05-10 收录

抑郁症药物

精神药物疗效评估

数据链接：

https://doi.org/10.25934/00006812 数据链接链接失效反馈

官方服务：

资源简介：

To compare the antidepressant efficacy and safety of DVS-233 SR versus placebo in adult outpatients with MDD.

应用场景：

创建时间：

2025-10-13

精神分裂症神经影像

精神药物疗效评估

This aim of this project was to use H2O15 PET technique to compare cerebral activation in patients with first-episode schizophrenia and normal control subjects during cognitive activation using the St

Research Data Australia160

The effect of sertraline on depression and associations with persistent depression in survivors of HIV-related cryptococcal meningitis

HIV神经认知障碍

精神药物疗效评估

Background: Depression is associated with worse outcomes in persons living with HIV/AIDS and has a prevalence more than three times as high as in the general population. Despite this, there are few ra

NIAID Data Ecosystem50

Single drug treatments & ASD sets.

自闭症谱系障碍药物

精神药物疗效评估

Single drug treatments & ASD sets.

Figshare2016-10-28 更新20

Short-term efficacy and tolerability of venlafaxine extended release in adults with generalized anxiety disorder without depression: A meta-analysis

精神药物疗效评估

广泛性焦虑障碍

BackgroundAlthough efficacy of venlafaxine extended release (XR) for generalized anxiety disorder (GAD) has been reported in previous analyses in 2002 and 2004, the sample size was rather small and es

Figshare2017-10-05 更新80

A Multi Centre, Double-Blind, Double-Dummy, Placebo-Controlled, Randomised, Adaptive, Dose-Range Study To Evaluate the Safety and Efficacy of SB-773812 Administered Once Daily for 12 Weeks in Adults With Schizophrenia

精神分裂症药物试验

精神药物疗效评估

This is a two part study designed to evaluate the safety and efficacy of SB-773812 in the treatment of acute schizophrenia. Subjects with acute schizophrenia will be randomized in an adaptive design s

DataCite Commons2025-05-01 更新40

Dataset from A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Flexible-Dose Study of DVS-233 SR and Venlafaxine ER in Adult Outpatients With Major Depressive Disorder

资源简介：

相关数据集